Selected outcome
Before Jan 1, 2030
48%
Before Jan 1, 2030 · 48%
Stored quote · checking the venue
- Scheduled end
- Dec 31, 2026 ET
- Resolution source
- Food and Drug Administration (opens in a new tab)
Price
Loading price history.
Markets
- Before Jan 1, 2029
Will the FDA approve midomafetamine / MDMA for PTSD before Jan 1, 2029?
47%
Open · ~$2 24h · ~$1,250 vol
Bid 44¢ · Ask 49¢
- Before Jan 1, 2027
Will the FDA approve midomafetamine / MDMA for PTSD before Jan 1, 2027?
9%
Open · ~$0 24h · ~$77 vol
Bid 6¢ · Ask 12¢
- Before Jan 1, 2028
Will the FDA approve midomafetamine / MDMA for PTSD before Jan 1, 2028?
35%
Open · ~$0 24h · ~$258 vol
Bid 32¢ · Ask 38¢
- Before Jan 1, 2030
Will the FDA approve midomafetamine / MDMA for PTSD before Jan 1, 2030?
48%
Open · ~$0 24h · ~$1,561 vol
Bid 45¢ · Ask 50¢
- Before Jan 1, 2031
Will the FDA approve midomafetamine / MDMA for PTSD before Jan 1, 2031?
48%
Open · ~$0 24h · ~$1,420 vol
Bid 46¢ · Ask 50¢
- Before Jan 1, 2032
Will the FDA approve midomafetamine / MDMA for PTSD before Jan 1, 2032?
49%
Open · ~$0 24h · ~$1,100 vol
Bid 46¢ · Ask 52¢
Event statistics
How this resolves
- Scheduled end
- Dec 31, 2026 ET
- Resolution source
- Trading
- Closed
- In review
- Resolved
Rules text
If the FDA approves midomafetamine / MDMA for PTSD for marketing before Jan 1, 2030, then the market resolves to Yes.